Pericapsular Nerve Group (PENG) Block versus lumbar plexus block for Hip Fracture; a prospective randomized controlled trial
Not Applicable
Not yet recruiting
- Conditions
- perioperative analgesia in patients undergoing surgery for hip fractures
- Registration Number
- PACTR202008796392872
- Lead Sponsor
- Faculty of Medicine Tanta University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age 18-70 years
either gender
ASA I-III
undergoing hip fracture surgery
Exclusion Criteria
Patient refusal
patients with any contraindication to regional anesthesia (e.g. local infection, coagulation abnormality)
known allergy to local anesthetics
mental disorders
drug or alcohol abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of PENG blocks in hip fracture patients?
How does PENG block compare to lumbar plexus block in postoperative pain management for hip fractures?
Are there specific biomarkers that predict better outcomes with PENG blocks versus lumbar plexus blocks?
What are the potential adverse events associated with PENG blocks in elderly hip fracture patients?
What combination analgesic strategies enhance PENG block efficacy in hip fracture surgery?